Pro-Euro-DILI Registry version 1

• Research type

  Research Study

• Full title

  Prospective European DILI registry: Creation of a multicentre and multidisciplinary European registry of prospective drug-induced liver injury cases.

• IRAS ID

  167142

• Contact name

  Guruprasad Aithal

• Contact email

  guru.aithal@nuh.nhs.uk

• Sponsor organisation

  Research & Innovation

• Duration of Study in the UK

  2 years, 0 months, 1 days

• Research summary

  The aim of this study is to set up a European registry of patients with idiosyncratic Drug induced Liver injury (DILI), enrolled prospectively with the collation of indepth phenotyping. We will enrol a similarly well-characterised control group of people who are exposed to medications matched for those implicated in DILI. We will collect and store biological samples (blood, urine, stool and liver biopsy) from the control group, and patients with DILI through the course (at onset and follow-up) of the event.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  15/YH/0294

• Date of REC Opinion

  18 Aug 2015

• REC opinion

  Further Information Favourable Opinion